Cell And Gene Therapy Videos

  1. OligoProcess™ Oligonucleotide Synthesizer Product Overview 2/3/2025

    Meet our OligoProcess™ oligonucleotide synthesizer – exceptional scale ranges in 3 different scale designs to fit your needs up to 1800 mmol and beyond.

  2. OligoPilot™ Oligonucleotide Synthesizer Product Overview 2/3/2025

    Meet our OligoPilot™ oligonucleotide synthesizer – the next generation oligo synthesizer with scales to 150 mmol.

  3. ÄKTA Oligosynt™ Oligonucleotide Synthesizer Product Demo 2/3/2025

    Meet our ÄKTA oligosynt™ oligonucleotide synthesizer – a small system with a big impact up to 12 mmol.

  4. FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish 1/31/2025

    Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.

  5. Capacity Update January 2025: Fill/Finish 1/31/2025

    This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.

  6. Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    See how Forge’s dedicated 200,000 sq. ft. facility, proprietary technologies, and specialized services provide expert AAV manufacturing to empower developers from discovery to delivery and every step in between.

  7. Andelyn Biosciences Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    Here we introduce the structure and capabilities of our Laboratory Services group, a cornerstone of our commitment to excellence in pharmaceutical development.

  8. Aldevron Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    In this session, you will discover how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA research and development pipeline.

  9. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  10. Elucidating The Role Of IL-18 In NSCLC Integrated Analysis 1/23/2025

    Hear how imaging mass cytometry, CyTOF, and single-cell sequencing unlock the secrets of the tumor microenvironment. Discover new insights into IL-18 and its impact on non-small cell lung cancer.